Results 111 to 120 of about 32,586 (241)

Apixaban and oral implications [PDF]

open access: yes, 2015
Background: Thrombotic disorders remain a leading cause of death in the Western world, and in this regard a number of anticoagulation treatment have been used, including heparins, fondaparinux, vitamin K antagonists ...
Bagán Sebastián, José Vicente   +1 more
core   +1 more source

Anticoagulants for acute ischaemic stroke [PDF]

open access: yes, 2015
Peer reviewedPublisher ...
Counsell, Carl   +2 more
core   +1 more source

Acute Coronary Syndromes: Management and Secondary Prevention [PDF]

open access: yes, 2018
Acute coronary syndromes represent a broad spectrum of ischemic myocardial events including unstable angina, non-ST elevation myocardial infarction and acute ST elevation myocardial infarction, which are associated with high morbidity and mortality. They
Wenaweser, Peter, Windecker, Stephan
core  

Extended Physicochemical Characterization of the Synthetic Anticoagulant Pentasaccharide Fondaparinux Sodium by Quantitative NMR and Single Crystal X-ray Analysis

open access: yesMolecules, 2017
Fondaparinux sodium is a synthetic pentasaccharide representing the high affinity antithrombin III binding site in heparin. It is the active pharmaceutical ingredient of the anticoagulant drug Arixtra®.
William de Wildt   +7 more
doaj   +1 more source

Traitement de la maladie thromboembolique veineuse [PDF]

open access: yes, 2018
Purpose: To describe the drugs used to treat venous thromboembolism (VTE) and to review particular aspects of the management (elastic stockings, thrombolysis, thrombectomy, vena cava filter).
Moerloose, Philippe   +2 more
core  

Smjernice Hrvatskog društva za hematologiju i transfuzijsku medicinu u dijagnostičko-terapijskom postupku za trombocitopeniju izazvanu heparinom (HIT) [Croatian Society for Haematology and Transfusion Medicine Guidelines on the diagnosis and management of heparin induced thrombocytopenia (HIT)] [PDF]

open access: yes, 2012
Heparin induced thrombocytopenia (HIT) is a serious complication of heparin administration. In the last decade, this clinical syndrome has come into the focus of interest, primarily because of the severe thromboembolic complications that may lead to ...
Bošnjak, Bojana   +15 more
core  

UEG Week 2025 Moderated Posters

open access: yes
United European Gastroenterology Journal, Volume 13, Issue S8, Page S189-S802, October 2025.
wiley   +1 more source

Trombopenia inducida por heparina. Revisión bibliográfica a propósito de un caso del Hospital Universitario de Basurto [PDF]

open access: yes, 2018
[ES] Revisión bibliográfica acerca de la epidemiología, patogénesis, presenación clínica, estrategias diagnósticas y abordaje terapéutico de la trombocitopenia inducida por heparina a propósito de un caso clínico del H.U.
Zorrilla Sarriegui, Ainhoa
core  

Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients

open access: yesDrug Design, Development and Therapy, 2016
Bruno Amato,1,2,* Rita Compagna,1,2,* Aldo Rocca,2 Tommaso Bianco,2 Marco Milone,2 Luigi Sivero,2 Gabriele Vigliotti,2 Maurizio Amato,2 Michele Danzi,2 Giovanni Aprea,2 Luca Gallelli,3,* Stefano de Franciscis,1,4,* Raffaele Serra1,4,* 1Interuniversity ...
Amato B   +12 more
doaj  

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist

open access: yesTherapeutics and Clinical Risk Management, 2018
Kazuhiro Shimizu, Takuo Iiduka, Shuji Sato, Hajime Kiyokawa, Takahiro Nakagami, Hiroshi Mikamo, Masayo Kawazoe, Mao Takahashi, Mahito Noro Department of Internal Medicine, Toho University Sakura Medical Center, Sakura City, Chiba, Japan Background: For
Shimizu K   +8 more
doaj  

Home - About - Disclaimer - Privacy